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ABSTRACT 
This paper explores how the type of consent given for organ donation should affect the judgment of a 
patient’s overall benefit with regards to donation of their organs and the pre-mortem interventions 
required to facilitate this. The findings of a qualitative study of the views of 10 healthcare 
professionals, combined with a philosophical analysis inform the conclusion that how consent to 
organ donation is given is a reliable indicator only of the strength of evidence about views on donation 
and subsequent willingness to undergo pre-mortem interventions. It is not an indicator of the strength 
of actual desire to donate. Clinical management of living patients prior to donation after circulatory 
death (DCD) must therefore respect the values, wishes and beliefs of the potential DCD donor. Our 
participants, however, suggested that the information currently provided is sufficient to authorise 
donation and that this consent, however provided, was sufficient to proceed with pre-mortem 
interventions. Respect for autonomy underpinned this ‘all or nothing’ approach. Although the legal 
requirements for donation authorisation and the protection of patients without capacity are clear, 
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practice and policy regarding consent in DCD may be based on donation following brainstem death 
(DBD) where the patient is already dead when the family is approached. Custom and practice in DCD 
may need to be revised to protect the interests of the dying potential donor.  
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BACKGROUND 
Donation after circulatory death (DCD) in the UK has increased from 61 cases in 2002-2003 to 507 in 
2012-2013.1 DCD may be less familiar to the lay public than donation after brainstem death (DBD), 
and raises ethical and technical issues that may not be foreseen by potential donors. In controlled 
DCD, the possibility of organ donation should be considered only after the decision that continuing 
life-sustaining interventions is no longer in the patient’s best interests.2 Maximising the chances of 
successful DCD donation and transplantation can, however, require invasive pre-mortem 
interventions, such as blood tests, bronchoscopies and insertion of a central line.3 These can seem 
incompatible with the prior decision to limit intervention; an apparent ‘moral mismatch’4.  
The interests of unconscious patients in England, Wales and Northern Ireland are protected by the 
Mental Capacity Act, 2005 (MCA). 5 Such interests are determined with reference to known wishes 
and any beliefs, feelings or values that relate to the decision in question. Relevant Scottish legislation6 
considers whether treatment ‘benefits’ a patients, determined with reference to present and past 
known wishes.   In line with existing GMC and UK Donation Ethics Committee (UKDEC) guidance,7,8 
we will use the term ‘overall benefit’ to refer to the treatment that is most appropriate to a patient 
without capacity, so that our discussion is applicable to legislation throughout the UK. When patients 
who are unconscious with no hope of recovery have previously indicated a wish to donate their 
organs after death, it may serve their overall benefit to become an organ donor. (UKDEC) state that 
where donation is ‘consistent with the patient’s wishes, values and beliefs, consideration of donation 
should become an integral part of that patient’s care in their last days and hours’9 provided that it does 
not undermine other interests such as avoiding burdensome invasive medical procedures, having a 
particular sort of death, and avoiding unwelcome burdens and harms for their loved ones. Healthcare 
professionals (HCPs) have, therefore, to determine (1) whether DCD is a realistic possibility, which is 
a clinical judgement and will not be discussed further here, (2) whether consent to donation has or 
can be secured and then (3) whether the pre-mortem interventions required for maximising the 
chances of successful donation and transplantation are consistent with providing overall benefit to the 
patient.  
In relation to (2), registration on the organ donor register (ODR) (where people can express their 
willingness to donate their organs) gives some indication of a patient’s prior wishes in relation to 
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donation. Indeed, registration amounts to an authorisation to remove organs for the purposes of 
donation under the Human Tissue Act10. In the case of absent registration, family and friends can 
authorise donation, but the Act places no obligation on them to make a decision (either for or against 
donation) that reflects the wishes of the patient, save where the patient is known to have objected. 
Discussion of whether or not this amounts to a coherent position, including revisiting well-trodden 
arguments in favour of opt-out or even mandatory systems,11,12,13 is beyond the scope of this paper. 
Wales has recently transitioned to an opt out system (and other devolved Governments may follow), 
but the current law throughout the rest of the United Kingdom is that organ donation should only go 
ahead if there is no indication that the potential donor would have objected to this and appropriate 
authorisation has been secured.10  
In relation to (3) the Organ Donation Taskforce argued that registration per se does not meet the 
standard of informed consent usually required in medicine and may not, therefore, justify the 
necessary pre-mortem interventions required for effective transplantation.14 The patient, whilst clearly 
expressing a wish to be a donor, might not have anticipated what donation entails and therefore in 
lieu of evidence to the contrary, it cannot necessarily be assumed that willingness to donate equates 
to a consent to everything that will make donation possible before death has occurred. Additional 
information about the strength of the desire to donate can be gained from family and friends. It may 
be reasonable to assume, absent evidence to the contrary, that the stronger the desire the more likely 
it is that interventions that make donation possible would have been acceptable to the patient.15 
Evidence of prior knowledge of what donation might entail could also be helpful.  Where there is no 
direct knowledge of the patient’s wishes, a judgement about overall benefit will need to be made in 
conjunction with family and friends, who can provide knowledge of whether the potential burdens of 
pre-mortem interventions can be justified in the light of the patient’s values, feelings and beliefs. The 
UK Code of Practice16 suggests that interventions should only be performed for the benefit of the 
patient and not solely to preserve organs. Accordingly, clinicians have to be confident that donation is 
of overall benefit to the patient to the extent that interventions prior to death are beneficial to the 
patient in terms of bringing about this benefit .17 
UKDEC8 has ranked the different kinds of consent to donation from strongest to weakest, based 
broadly upon the strength of evidence for the patient’s desire to donate (table 1). The first three 
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categories in the UKDEC hierarchy feature the known donation wishes of the patient, whereas the 
latter three rely on family or nominated representatives to ‘construct’ these wishes on the basis of 
other criteria. All forms of consent are sufficient for organ donation to proceed but demonstrate 
progressively weaker indications of the patient’s known wishes. Because there is no clear-cut 
relationship between (2) and (3), consent to donation in relation to DCD is more complex than in the 
case of DBD, where the interests of the patients are changed (but not completely negated) by death. 
Moreover, the process of DCD can place even greater burdens on the family/friends of the patient 
because the period between making the decision about donation to the donation itself may be lengthy 
and there will be understandable concerns to safeguard the interests of the patient to die with as 
much dignity and comfort as possible. Equally, it may be reasonable to assume, absent clear 
indications to the contrary, that the patient would want to balance consideration for family and friends, 
as well as any burdens on him/herself, with the desire to donate organs to help a stranger. If the 
patient is known to have had a strong desire to donate and a full understanding of what this may 
entail, it may be reasonable to suppose that the burdens of pre-mortem interventions may be 
outweighed by their interest in having their wishes in relation to donation fulfilled. We might also 
suppose that the less this is the case, the harder it will be for clinicians to judge whether these pre-
mortem interventions can be considered in the overall best interests of the potential donor.  
Some assumptions have been made regarding donors wanting to donate their organs at ‘maximal 
viability’,18 and some interventions such as elective ventilation have been (not uncontroversially) ruled 
unlawful.19  We were unable, however, to find any literature on how clinicians balance information in 
relation to DCD, in particular in relation to (3). We wanted to understand more about what 
practitioners thought about the relationship between the way in which consent is provided and the 
assessment of the relative benefits and burdens of pre-mortem interventions necessary to facilitate 
successful DCD. To this end, we designed a small qualitative study in which we asked practitioners 
about consent and DCD through a series of scenarios (see table 2) designed to encourage them to 
assess the intervention burden in light of the way that consent was given.  
METHODS 
As this is an area in which there is no existing literature, making it likely that new ideas and theories 
would emerge, face-to-face interviews were undertaken to allow for in-depth descriptions of complex 
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phenomena.20 The interviews were semi-structured to provide consistency, whilst also allowing 
participants to raise relevant issues important to them. The topic guide (table 2) provided uniformity, 
structure and anticipated general key issues identified by a pilot interview conducted prior to the 10 
interviews through which data were collected.  
The research population included all nurses and doctors working in areas likely to be involved in DCD 
from the Intensive Care Unit (ICU) in a large inner city hospital that is also one of the major transplant 
centres for the UK. Professionals working within the ICU provide the majority of care for potential 
DCD donors including pre-mortem interventions. Therefore, it is this particular group of HCPs that are 
most likely to have experienced any ethical tensions21 that arise when making decisions about 
potential DCD donors.. An invitation email and participant information sheet were emailed to all 
potential participants.  All those willing to be interviewed were included and the only exclusion 
criterion was being unable to arrange a convenient interview time. 10 positive responses were 
received and all interviews were conducted between February and March 2014 (table 3). 
Permission for the study was gained from the Trust R&D following favourable review by <identifying 
information withheld> ethics committee. 
The data was initially coded against a predetermined framework to target areas of interest identified 
from an initial philosophical analysis of the ethical issues involved. These included best interests, 
consideration of the interests of others and views about consent. A separate code termed ‘new issues’ 
was allocated to any ideas or lines of argument that had not been foreseen. Analytic memos were 
used to increase familiarity with the data and begin the analytical process.22 Focused Coding23was 
used for the second coding cycle. This enabled the development of major categories and themes 
through the search for the most frequent and salient initial codes.  
A short report of the interpretation of each participant’s views was emailed back to the participant as a 
form of member validation,24 which allowed them to check/correct the researcher’s interpretation and 
add any additional comments. Those who replied (n=4) agreed with the researcher’s interpretation. 
Once these stages were completed by <identifying information withheld>, <identifying information 
withheld> independently checked the coding and the two researchers discussed the analysis and 
came to an agreement about the interpretation.
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RESULTS 
Four main themes were identified 1) donation reflects the consenting patient’s overall benefit 2) non-
maleficence 3) types of consent and 4) the information provided for consent.  
Participants’ opinions regarding the necessary pre-mortem interventions required for DCD held across all 
three scenarios discussed in the interviews. The results therefore focus on participants’ reasons for 
agreeing or disagreeing with such interventions as opposed to the differences between the scenarios.  
Due to their location in an English hospital, participants tended to refer to ‘best interests’ rather than the 
‘overall benefit’ referred to throughout this paper. We take these terms to be broadly synonymous, so 
although quotations refer to ‘best interests’, we will continue to use ‘overall benefit’ in our discussion.   
Donation reflects the consenting patient’s overall benefit 
The view held strongly by the majority of the participants was that DCD and the necessary pre-mortem 
interventions were of overall benefit to a consenting patient. Consent was regarded as an indication of a 
patient’s wishes and it was of overall benefit for these wishes to be respected.   
P8: Generally, it’s [organ donation] in a patient’s best interests if they have wanted to donate their 
organs after death. 
P6: You need to respect all of her wishes and if she wants that to go ahead in this situation then we 
need to try and facilitate that.  
As well as the interest in wanting to donate, it was considered of overall benefit to the donor and thus, the 
duty of HCPs, to maximise the potential and quality of the organs.  
P1: We have a duty to the donor, to the recipient to make sure we’re transplanting organs in 
optimum condition.  
P5: [T]he hospitals and the trust should do...everything possible to make these organs as optimal 
as possible in the recipient body. 
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Non-maleficence  
Although it was felt that patients’ wishes regarding organ donation should be respected, any procedure 
that caused the patient physical distress or went against the wishes of the family was considered wrong 
by all participants. Whilst it was universally agreed that the wishes of the patient should be regarded as 
decisive even if the family expressed conflicting wishes, none of the participants would go against the 
wishes of the family. Participants pointed out that pre-mortem interventions necessary for donation did not 
cause distress because the patients would be unconscious and sedated.  
P3: [T]he bottom line is always do no harm and you know, cause no distress for the family.  
It was often suggested that patients were harmed by not respecting their wishes to donate.  
P8: If they say they want to donate, and you don’t do that, then you’re sort of disrespecting their 
last wishes and you’re doing harm by them. 
One of the harms that participants sought to avoid was an undignified death for the patient meaning that 
the pre-mortem interventions should not compromise the experience of death for the family or patient.  
P7: I think we’ve got the right to dignity, as long as dignity is provided, I have no problems with 
additional tests on somebody who is dying.  
Some thought that patients would strongly disapprove of HCPs being overly fastidious about avoiding 
pre-mortem interventions, that the technicalities regarding the definition of death were being taken too 
seriously and the fulfilment of the patient’s wishes not seriously enough. 
P1: You’re doing what they want you to do, just get over it…it’s interesting because it was the lay 
people on the ethics committee [that considered the issue of withdrawing treatment prior to DCD] 
that said ‘you what?’ They basically said, ‘you patronising so and so’s. I want to donate my 
organs… And you’re gonna say that I can’t donate my organs because you’re too squeamish to 
pull my tube out?’  
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One participant, however, was extremely apprehensive about all pre-mortem interventions, thinking that 
they might result in a slippery slope towards elective ventilation and other controversial practices if the 
wish to donate was privileged unreservedly. This view held for all patients, regardless of the type of 
consent given. 
P4: Do we then get to the point where we then respect their wishes to donate so much that we 
should keep them alive until... a recipient becomes available?... [E]ven with a femoral line, you 
could well prang the artery. Are we then going to start giving blood transfusions? And resuscitate 
them?  
Types of Consent 
Two participants said their practice was influenced by the strength of the desire to donate: interventions, 
such as a bronchoscopy, were only regarded as permissible if the patient had been especially passionate 
about organ donation.  
P3: In my practice I base this very much on how much consent or what this patient’s feelings 
were. So I have some patients where I say I will do everything. 
However, the majority of participants did not regard the type of consent given as an important 
consideration in which pre-mortem interventions could be considered morally acceptable. Consent to 
organ donation was predominantly regarded as consent for whatever procedures were required to 
facilitate this end.  
P1: [I]t’s a binary response isn’t it…it’s either right to proceed with donation or it’s not. It’s not a bit 
more right, sort of, so you do a bit more tests on that one. I think it’s... an on/off thing isn’t it?  
 
Information provided for consent 
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Opinions were divided about whether consent for organ donation, specifically DCD, was sufficiently 
informed. Some participants thought that in normal medical practice, when one procedure may result in 
another, patients are usually told; this norm suggested that consent for DCD is not sufficiently informed 
because information about the procedure itself and/or the interventions that may need to precede it, is not 
provided by the current consenting system for organ donation. 
P9: I think that more information is needed about what happens, erm cos they’re just agreeing to 
be an organ donor, without actually knowing what has to be done. And quite a lot of the 
procedures are quite invasive erm so I think it’s important. 
Some participants claimed the information provided prior to consent for DCD did meet the threshold 
applied for normal medical procedures. This was because it was felt that providing extensive information 
about any procedure was not usual.  
P7: Well I think it’s as informed as anything else. 
Some participants felt that sufficient information on organ donation, including DCD was widely available 
and that this information was adequate to meet the needs of the lay public. It was suggested that because 
this information was widely available, patients who did not access it were choosing not to do so.  
P2: [I]nformation is available...whether or not donors choose to use that information is a personal 
choice… I do think it’s true to say that many patients, many donors, choose not to know. 
Some participants felt that patients assumed that as they would be dead at the time of donation, and 
insensate in the period leading to donation, they would not consider the details of the DCD procedure and 
its preceding interventions to be important. Some participants felt that the level of trust between patients 
and clinical staff meant that they did not need detailed information about the process of DCD.  
P1: The notion of informed consent is that they know it’s not informed. Intelligent people know 
that it’s not informed and they accept that…they accept that as part of the contract of trust they 
have with you and I.     
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LIMITATIONS 
This study was conducted in one transplant centre and only involved staff working in intensive care. Ten 
participants from the targeted ITU population were interviewed and it is possible that data saturation was 
not achieved. Consultants were overrepresented in the sample and junior doctors, registrars and nurses 
were under-represented. Consultants will, however, usually have ultimate responsibility for decisions 
regarding end-of-life care and so their views are likely to be the most influential in guiding practice. Data 
were not collected from potential donors or donor families, so further research involving these 
stakeholders may provide alternative perspectives and would be a useful addition to the discussion of this 
topic.   
DISCUSSION 
Donation reflecting the overall benefit to patients 
Participants did not draw a distinction between ‘best clinical interests’ and ‘overall benefit’ but clearly 
understood patients to have interests that extended beyond receiving optimal clinical care. A known wish 
to donate organs was regarded as having an interest in being a donor, including where this wish was 
reported by a family member or based on a patients known values, beliefs and feelings. This closely 
reflects the current guidance on how to interpret the MCA in the context of DCD, and it consistent with 
similar interpretations17 including those outwith donation,25 expressed elsewhere.  
Establishing overall benefit in relation to DCD is, however, likely to be more complex than this. A minority 
of participants believed that pre-mortem interventions to facilitate organ donation should not compromise 
the experience of death for the patient or family, which highlights that a patient’s interests in becoming a 
donor could be in conflict or intertwined with the interests of their family. As noted above, it may be 
reasonable to assume that, absent evidence to the contrary, a dying potential DCD donor would not 
consent to an intervention that would add disproportionately to distress experienced by family/friends; 
administering such an intervention would not then be justifiable with reference to their desire to donate.6 
This is not necessarily the case, however, and a patient could have valued donating organs over the    
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interests of their family/friends. If this is the case, however, it is likely that this would be known to the 
family/friends, and the strength of feeling reported by them to the clinical team. Where this is not the case, 
it is not obvious where the balance should lie, especially where accounts of the patient’s wishes are 
ambiguous or based on suppositions formed by applying more generally known values and beliefs. It 
should not, perhaps, be left to the family/friends alone to suggest that the patient may also have had an 
interest in safeguarding their interests but it may be difficult for clinicians to judge the extent to which DCD 
is adding to their distress in already difficult circumstances.  Some of our participants did seem sensitive 
to the effect on the family but this was not clearly tied in our data to the interests that the patient might 
have in their well-being even though decisions under the MCA should not be motivated by consideration 
of anyone other than the patient.  
Does an interest in donating organs imply that undergoing pre-mortem interventions to facilitate 
donation is of overall benefit? 
Although the conflicting interests of others should not be considered relevant (in their own right) when 
assessing whether donation or treatment to facilitate donation should go ahead, the same is not true of a 
patient’s own competing interests. A patient may have an interest in becoming a donor, but they may also 
have an interest in avoiding pain, invasive procedures and having their life shortened or extended by 
interventions. Some participants thought that patients who had consented to organ donation would want 
their organs to be donated in an optimal condition for successful transplantation even if this required 
further interventions, and they therefore felt that they had a duty to facilitate this. Although this may be a 
reasonable assumption in many cases, it is again not necessarily correct, and may disregard important 
competing interests. Taking a blood sample for tissue-typing purposes and thereby causing a small 
puncture wound would most likely be considered a minor countervailing consideration, and therefore be 
readily outweighed by a known wish to donate. In contrast, however, a test that required transfer to a 
different location with a significant risk of the patient dying whilst in transfer without relatives by their 
bedside could be a more significantly countervailing consideration, so much so that it could override any 
expressed wish to become an organ donor.     
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Whilst there is a considerable literature about how interventions prior to DCD can contribute to the 
transplantation of organs in their optimal condition,26, 27 the views of those who have to interpret whether 
the wish to donate implies consent to undergo any or all procedures necessary to facilitate optimal 
transplantation have not been explored previously. It has been argued elsewhere that an interest in 
donating may reasonably also constitute an interest in the donated organs being transplanted 
successfully, but that this stops short of also implying that a donor has an interest in the condition of their 
organs being optimised25. This has implications for determining which pre-mortem interventions are 
permissible. Interventions to improve the chance of successful donation and transplantation may 
therefore have to be considered quite differently from interventions intended to bring about the best 
possible outcomes for the recipient.   
Participants unanimously supported avoiding all pain and distress to the patient, and this again accords 
with the current guidance on DCD1. Many participants, however, did not seem to consider that invasive, 
albeit fairly painless, interventions such as a blood test that delayed the withdrawal of life-sustaining 
treatment, as compromising the interest of the donor even though a prior judgement had been made that 
withdrawing life-sustaining treatment was of overall benefit to the patient. The most important interest was 
considered to be the facilitation of DCD, and consequently the primary negative outcome, other than 
causing physical distress and an undignified death, was preventing the procurement of organs in their 
optimal condition. This may reflect an assumption by the participants about how patients rank their 
interests. Those who would go ahead with the pre-mortem interventions regardless of the type of consent 
given focussed solely on the benefits of organ donation, perhaps an unsurprising outcome for those 
seeing the benefit of organ donation so often in their working lives. Interests in avoiding relatively 
unburdensome pre-mortem interventions were dismissed in favour of the idea that registering on the ODR 
or agreeing that donation was something a patient would have wanted was compatible with accepting the 
necessary measures to achieve donation. Only two participants expressed contrary views that recognised 
potentially conflicting interests in such situations and subsequently attempted to balance both sides 
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before arriving at a decision regarding which interventions could be considered morally permissible, as 
recommended by recent UKDEC guidance8.  
Whilst it seems reasonable to assume that an interest in avoiding non-therapeutic interventions is 
outweighed by a very strong desire to be an organ donor where the burdens are unsubstantial, it is 
nonetheless important that this interest is not completely overlooked and efforts should be made to 
establish and weigh up/aggregate any potentially competing considerations in the build-up to donation in 
order to establish what is of overall benefit. 
One participant felt that any intervention ‘interfering’ with the patient’s death was wrong, but this position 
may go too far in the other direction. Competing interests such as the interest in avoiding invasive 
interventions should be considered relative to the desire to donate: to not do so has serious and ‘far-
reaching ramifications in terms of conflicts of interest’28. Obstacles should not be placed in the way of 
donation by patients who would have agreed to the pre-mortem interventions necessitated by DCD, and 
barriers should be erect to protect those who would not agree to the unnecessary prolongation of their 
dying process. Our data suggests that by regarding consent as binary, staff may not be sufficiently 
sensitive to the different interests in play in DCD, as we will now discuss.  
Consent to donation and consent for pre-mortem interventions 
The acceptability of pre-mortem interventions hinges on a patient’s interest in avoiding burdensome pre-
mortem interventions relative to their interest in being an organ donor. As few patients are likely to have 
left specific instructions covering this eventuality for practical purposes their wishes are unknowable. We 
must therefore look primarily to wishes in relation to the latter to establish the acceptability of pre-mortem 
interventions. The topic guide was designed to highlight relevant differences in how consent/wishes about 
organ donation were established. However, only two participants considered how differences could 
impact upon the permissibility of pre-mortem interventions.  
At first glance, the varying ways in which consent can be given, as described by the UKDEC hierarchy, 
may seem like a promising indicator of whether pre-mortem interventions are of overall benefit to a    
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patient based on a sliding scale for the strength of evidence for a patient’s wish to donate: ‘[t]he stronger 
the evidence of the patient’s desire to become an organ donor, the greater the weight this should be 
given in assessing whether a particular intervention would be in the patient’s best interests.’6 If a patient 
has clearly recorded their wishes about donation by joining the ODR, it is tempting to assume that there is 
a strong case for pre-mortem interventions to facilitate donation. However, the weakness of this 
assumption is that whilst the strength of evidence may be affected by the way in which consent is given, 
this gives no clear evidence of a much more important consideration: the potential donor’s strength of 
desire to donate. This would not be problematic if information provision prior to joining the ODR was 
sufficient to ensure that all registrants understood the possibility of pre-mortem interventions to facilitate 
DCD, but as will be discussed shortly, this is not the case.  
Joining the ODR indicates a patient has a desire to donate, but it does not say anything about the lengths 
to which they would be willing to go for donation to be facilitated: the strength of their desire. Indeed it 
may be that once a potential donor is unconscious, the strength of her desire to donate can only be 
gauged by speaking to family members about her beliefs, feelings and values. In this respect, types of 
consent iv and v on the UKDEC list could be a better indication of desires with respect to DCD than ii and 
iii if the question of whether the patient’s values and beliefs would suggest agreement to pre-mortem 
interventions is addressed directly with those who know that patient best. Yet, as we will now discuss, our 
participants did not necessarily agree that the detailed information that such a judgement would require is 
being, nor should be, disclosed at the time consent is sought.  
 
Information provided for DCD 
Although many participants did not consider pre-mortem interventions to be ethically problematic, the fact 
that potential DCD donors, and their families, may be relatively uninformed about the donation processes 
still raises ethical concerns.  
Most participants seemed to assume that potential donors and their family/friends do not require any 
specific information regarding DCD and associated pre-mortem interventions. This would imply that they    
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believe consent to organ donation amounts to tacit consent for whatever procedures are required to 
facilitate it. This position is potentially problematic, however, because the informational requirements of 
consent for DBD are different from the informational requirements of consent for interventions while 
alive.29,30 A person can join the ODR knowing little or nothing about organ donation or what it entails. 
There is no mechanism for checking understanding at the point of registration. This may be because DBD 
was, until recently, the most likely donation pathway. DCD, on the other hand, entails invasive medical 
procedures during life, and it may therefore be reasonable to anticipate a greater need for information to 
ensure valid consent for DCD. 
Consider the following: if Mr X consents to Mr Y staying in his house whilst he is away but Mr Y loses his 
key, should we assume that Mr X has tacitly consented to Mr Y breaking down the door to gain access to 
the house? Probably not, as Mr Y did not foresee that Mr X would lose the key and that the only way to 
access the house would be to break down the door. Of course, Mr X could be asked whether he minds. If 
Mr Y is habitually careless, friends may even warn Mr X of the potential consequences of his generosity. 
Similarly, if a patient has consented to organ donation but is not aware of the pre-mortem interventions 
this may involve, she may not be said to have consented to all and any actions on her living body 
required to maximise the chances of a successful donation and transplant. 
Some participants asserted that consent for DCD was equivalent to non-transplant decisions and patients 
were generally not fully informed unless they asked to be. Participants suggested that trust in the medical 
profession meant that patients did not require information detailing medical procedures. In the case of 
non-transplant procedures trust in doctors is not unreasonable given that they are professionally bound to 
exercise their expertise for their patients’ therapeutic benefit.31,32 However, DCD  and the interventions 
required to facilitate it are not  of therapeutic benefit to the donor, but are instead justified with reference 
to broader overall benefit. The current system of consent and provision of information for organ donation 
means that overall benefit can be difficult to establish. Given the increasing shift from DBD to DCD the 
time may be ripe for providing more detailed information at the point of entry to the ODR. This would 
provide a clearer indication of the wishes of the potential donor who is on the register and may also have    
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the effect of generally increasing awareness of what DCD entails so that when such issues are discussed 
ahead of the need to make a decision (as we are all being encouraged to do) family/friends will be better 
placed to provide insight in to how to strike a balance between the various interests in play in relation to 
pre-mortem interventions.  
CONCLUSIONS 
The pre-mortem interventions required to ensure that a DCD donation is successful can only be justified if 
they are considered of overall benefit to the patient. . Our results suggest that those caring for potential 
DCD donors may be running together consent for organ donation with consent to pre-mortem 
interventions that may be necessary to facilitate donation. It is possible that their binary view of consent to 
donation as being either given or withheld is rooted in DBD.  It may also be a pragmatic response: there 
is normally very little recorded evidence about a patient’s wishes regarding pre-mortem interventions. To 
insist on clear evidence of prior potential donor consent to each and every pre-mortem procedure is 
probably setting the bar too high. Our  data suggest, however, that some clinicians believe that neither 
patients nor family/friends want detailed information about the procedures necessary to facilitate DCD.  A 
system that encourages them to choose how much information they want might prevent unwarranted 
assumptions being made on this score. Nonetheless, it remains the responsibility of clinicians not to 
provide interventions that are not of overall benefit to their patients. Where the interventions required are 
more burdensome, greater evidence may be needed of the strength – or likely strength – of the desire to 
donate. Given how little information is provided at the point of registration onto the ODR, few assumptions 
regarding a patient wishes can be deduced from one’s presence as registered donor. As the demand for 
transplantation increases and fuels the on-going drive for increased numbers of donors, there is a risk 
that the emphasis is being placed on the legal authority to remove organs for the purposes of donation 
and insufficient weight is being given to ensuring quality of consent being given. Greater transparency 
about the impact that being an organ donor can have on the dying process when joining the ODR may 
make it easier to assess the strength of people’s desire to donate, and therefore their willingness to 
undergo any necessary pre-mortem interventions. It may also help to have more precise options in terms    
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of what people can register for. For example, people could opt to register only for DBD, for DCD with only 
minimally invasive and burdensome interventions or for DCD by any means required in order to facilitate 
organ donation. This suggestion reflects UKDEC’s direction of travel15.  
There is obviously a balance to strike, however. Giving more options to people joining the ODR may 
cause confusion and wrongly deter people from becoming registered donors. Equally, however, more 
options may help to strike the balance between removing obstacles to willing donation and erecting 
barriers to protect those whose interests lie elsewhere. 
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TABLES 
Table 1: Hierarchy of Consent in Organ Donation (UKDEC, page 17) 
Category Description 
i Donors who have both consented to donation and agreed to undergo any procedures 
which would increase the probability of a successful transplant 
ii Donors who have simply consented to donation by joining the ODR, signing a donor 
card or advance directive 
iii Donors who have consented to donation (communicated by their family) without 
performing one of the formalities in (ii) 
iv Donors for whom consent is provided on the basis of their wishes and feelings 
v Donors for whom consent is provided on the basis of their wishes and values that 
would be likely to influence their decision 
vi  Donors for whom consent is provided although there is little or no evidence of their 
wishes and feelings on donation, or that donation would be consistent with their beliefs 
and values 
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Table 2: Topic Guide 
Preamble and consent 
1. To what extent do you think that DCD can be in a patient’s best interests?  
2. To what extent do you view consent in organ donation as informed consent?  
3. Discussion of scenarios 
a) Mrs. Green is 45 and has a brother who recently had a liver transplant. As a result, she has signed up to the 
Organ Donor Register and made her family aware of her desire to donate her organs. She feels very 
passionate about this and has told her daughter that she doesn’t want anything to ‘go to waste’.  
For the purpose of facilitating organ donation: 
- To what extent do you think it would be reasonable to test liver function via a blood test? 
- To what extent do you think it would be reasonable to carry out a bronchoscopy on Mrs. Green to remove 
secretions? 
b) Tom is 17 and signed up to the Organ Donor Register during the recent Facebook campaign whilst he was 
drunk at a party. His family are not aware that he on the register as he never mentioned it and it did not come 
up in conversation.  
For the purpose of facilitating organ donation: 
- To what extent do you think it would be reasonable to test liver function via a blood test? 
- To what extent do you think it would be reasonable to carry out a bronchoscopy on Tom to remove 
secretions? 
c) Mrs. Smith is a 65-year-old widow with no children. She is not on the Organ Donor Register and does not 
have an organ donor card. A sister is traced. Her sister gives her consent to donation saying that although she 
had rather lost touch with Mrs. Smith over the years, she is sure her sister was a nice person who would have 
wanted to help others.  
For the purpose of facilitating organ donation: 
- To what extent do you think it would be reasonable to test liver function via a blood test? 
- To what extent do you think it would be reasonable to carry out a bronchoscopy on Mrs. Smith to remove 
secretions? 
If they have said yes to all of the above questions, ask them if they can give any examples of an intervention 
that is too burdensome and therefore not appropriate. 
4. Having discussed all the scenarios, would you like to change any of your previous responses? 
5. Are there any other issues regarding this topic that you think are important and that I should take into account in 
my research?     
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Table 3: Participant Characteristics and Interviews  
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Participant Job Title  
M:F 
Length of 
Interview (mins)  
Reply to member 
check? 
1 Anaesthetic and Intensive Care Consultant   32  No 
2 Anaesthetic and Intensive Care Consultant   26.5  Yes  
3 Anaesthetic and Intensive Care Consultant   40.5  Yes 
4 Anaesthetic and Intensive Care Consultant   23  No 
5 Anaesthetic and Intensive Care Consultant   22  Yes 
6 Specialist Nurse in Organ Donation  31.5  No 
7 Anaesthetic and Intensive Care Consultant   23.5  Yes  
8 Junior Doctor (F2) on Intensive Care 
Rotation 
 26.5  No 
9 Anaesthetic and Intensive Care Consultant   25  No 
10 Specialist Nurse in Organ Donation  21  No 
Summary 7/10 Consultants 6: 4 27 minutes 
average  
4 responses to 
member check 
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